Our study demonstrated that hepatic Dio1 expression and activity are increased in early NAFLD, and blocking Dio1 induction by shRNA increased hepatic triglyceride and cholesterol content. The gene discussed is DIO1; the disease is metabolic dysfunction-associated steatotic liver disease.